Getting Out Of A Jam: Titan Medical Pulls Itself From The Brink With Medtronic Deal
Titan Medical has met all the milestones of partnership with Medtronic and is continuing to develop its Enos single-port robotic system.
You may also be interested in...
Operating on slim margins towards the launch of its Enos single port surgical robot, Titan Medical needs to refocus its efforts to succeed, according to its new CEO Cary Vance.
Liquid biopsy represents potential advantages over traditional approaches to cancer surveillance, treatment selection and recurrence monitoring. But one size does not fit all, requiring tailored solutions for less developed markets.
The company has enrolled the first patient in the second human trial of its implantable metabolite monitoring system, which it expects could change the game for blood glucose measurement.